New studies reinforce evidence that corticosteroids improve survival rates among critically ill COVID-19 patients, NIHR

Four papers published today on the use of corticosteroids to treat COVID-19 have reinforced evidence that outcomes for severely affected patients can be significantly improved by using these inexpensive and widely available drugs, with one paper suggesting the risk of death can be reduced by up to 20%. The papers - simultaneously published in the Journal of the American Medical Association (JAMA) - include findings from the REMAP-CAP study being conducted across 15 countries, around the world and for which the NIHR ' s Clinical Research Network and partner research institutes from devolved nations recruited close to 71% of all study participants.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news